期刊文献+

老年代谢综合征与VEGF的关系

下载PDF
导出
出处 《放射免疫学杂志》 CAS 2006年第6期504-507,共4页 Journal of Radioimmanology
  • 相关文献

参考文献26

  • 1Ferrara N,Henzel WJ.Biochem biophys.Res Commun.1989,161(2):851.
  • 2Joukov V,Sorsa T,et al.Proinflammatory cytokines regulate expression of the lymphtic endothelial mitogen vascular endothelial growth factor-C.J Biol Chem.1998,20:273(12):6599.
  • 3Leung DW,cachiants G,et al.Vascular endothelial growth factor is a secreted angiogenic mitogen.Science.1989,246 (4935):1306.
  • 4Tischer E,Mitchell R.The human gene for vascular endothelial growth factor:multiple protein forms are encoded through alternative exon splicing.J Biol Chem.1991,266 (11):947.
  • 5David W leung.Vascular endothelial growth factor is an secreted angiogenic mitogen.Science.1989,87(7):2628.
  • 6邓志宏,黄维国,金岩,邱建华,王锦玲.成纤维细胞生长因子及血管内皮生长因子在喉粘膜上皮中的分布及作用[J].第四军医大学学报,1998,19(1):70-72. 被引量:11
  • 7Neufeld G.Vascvalar endothelial growth factor and its receptors.Prog Growth Factor Res.1994,5:89.
  • 8Soker S.Vascular endothelial growth factor is inactivated by binding to alpha2-Macroglobulin and the binding is inhibited by heparin.J Biol Chem.1993,15:268(11):7685.
  • 9Collins PD,Connolly DT,Williams TJ.Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo.Br J Pharmacol.1993,109(1):195.
  • 10Robert B.Between molecules and morphology.Extracellular matrix and creation of vascular form.Am J Pathol.1995,147(4):873.

二级参考文献13

  • 1Noguchi K, Yoshikawa N, Itokariya S, et al. Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerrulonephritis. J Am Soc Nephol, 1998, 9:1815-1825.
  • 2Ferrara N, Winer J, Burton J, et al. Aorrie smooth muscle cell sexpress and secrete vascular endothelial growth factor. Growth Factors, 1997,5 : 147-151.
  • 3Kranz A, Rau C, Kochs M, et al. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance [J]. J Mol Cell Cardiol, 2000,32: 65-72.
  • 4Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical and experimental evidence of prostagland in E1-induced angiogenesis in the myocardium of patients with ischemic heart disesse[J]. Cardiovasc Res, 2002,56:214-224.
  • 5Salven P, Teerenhovi L, Joensuu H, et al. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma[J]. Blood,1997, 90: 3167-3172.
  • 6Arras M, Ito WD, Scholz D, et al. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb [J]. J Clin Invest, 1998, 101: 40-50.
  • 7Hojo Y, Ikeda U, Zhu Y, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction[J]. JACC, 2000, 35: 968-973.
  • 8Sasaki Y, Kawamoto A, Iwano M, et al. Vasculare endothelial growth factor mRNA synthesis by peripheral blood mononuclear cells in patients with acute myocardial infarction[J]. Int J Cardiol, 2001,81:51-60.
  • 9Salgado R, Vermeulen PB, Benoy I, et al. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients[J]. Br J Cancer, 1999, 80:892-897.
  • 10Maliney JP, Silliman CC, Ambruso DR, et al. In vitro release of vascular endothelial growth factor during platelet aggregation [J]. Am J Physiol Heart Circ Phy, 1998,44: H1054-H1061.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部